Classement en actions
#19673
IntegraGen SA provides human genome analysis services for academic researcher... IntegraGen SA provides human genome analysis services for academic researcher and life sciences companies in France. Its genomic services include transcriptomics, epigenomics, DNA sequencing, NGS testing for cancer research, and SNP genotyping. The company offers clinical research services, such as clinical grade sequencing and pharmacogenomics; basic and human genetic research; agrigenomic services, including crop and livestock genotyping and high-throughput sequencing for crops and livestock; and microbial genomics services comprising whole-genome microbial sequencing and microbial transcriptomics. It also provides MERCURY, an online biological interpretation tool for oncology intended to assist pathologists and oncologists in transforming raw data obtained through high-throughput sequencing into a molecular report for translational and clinical research use; SIRIUS, a cloud-based software tool that enables researchers to analyze whole genome, whole exome, and gene panel sequencing data; Galileo, a cloud-based app for dynamic exporation of RNA-Seq expression data; and GeCo, a genomic consulting service that offers researchers with access to biostatistics and bioanalytics experts. IntegraGen SA was founded in 2000 and is headquartered in Évry, France. IntegraGen SA is a subsidiary of OncoDNA SA.
Prix de l'action
$0.20342561
Capitalisation boursière
$1.34M
Changement (1 jour)
-1.44%
Changement (1 an)
-65.74%
Échange IntegraGen SA (ALINT)
Le prix ALINT avec la capitalisation boursière de B
Capitalisation boursière de IntegraGen SA(ALINT)
Capitalisation boursière: $1.34M
En July 2026, IntegraGen SA a une capitalisation boursière de $1.34M. Cela fait de IntegraGen SA la 19673rd entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de IntegraGen SA du 2010 au 2026
ALINT par rapport au top 5 des plus populaires stocks
| Prix pour ALINT |
|
L’actif B |
La capitalisation boursière de B |
Résultats |
|
|
|
|
$4.786T
|
+356,072,364.50%
|
|
|
|
|
$4.349T
|
+323,624,881.22%
|
|
|
|
|
$4.324T
|
+321,703,012.19%
|
|
|
|
|
$2.855T
|
+212,396,791.78%
|
|
|
|
|
$2.600T
|
+193,452,778.42%
|
